To perform their surveillance functions, T lymphocytes traffic from the vasculature to secondary lymphoid organs, where they scan for antigenic peptides on cell surfaces 1,2 . In the confinement of these organs, T cells complete a circuit in search of antigen-presenting cells bearing complexes of peptide and major histocompatibility complex. This task is presumed to involve the competing need to carefully survey every surface while also avoiding excessive adhesion that leads to lower motility. The complex choreography of T cell migration has been observed by two-photon microscopy 3,4 ; however, the molecular factors that coordinate this process are not well understood.
A r t i c l e s
To perform their surveillance functions, T lymphocytes traffic from the vasculature to secondary lymphoid organs, where they scan for antigenic peptides on cell surfaces 1, 2 . In the confinement of these organs, T cells complete a circuit in search of antigen-presenting cells bearing complexes of peptide and major histocompatibility complex. This task is presumed to involve the competing need to carefully survey every surface while also avoiding excessive adhesion that leads to lower motility. The complex choreography of T cell migration has been observed by two-photon microscopy 3, 4 ; however, the molecular factors that coordinate this process are not well understood.
According to the haptokinetic model, in mesenchymal cells, the density of integrin substrate modulates the optimal rate of motility in two-dimensional environments 5, 6 . However, it would seem that integrins on their own are not the main determinant of migration for leukocytes in vivo, and they have been shown to be largely dispensable for amoeboid migration in dense collagen matrices and in vivo [7] [8] [9] . As a general rule, protrusion and force generation during motility are mediated mainly by the actomyosin cytoskeleton through actin polymerization and contraction of the actin network by class II myosin [10] [11] [12] . However, the fundamental mechanisms of this process and the factors that regulate motility, particularly in vivo, are yet to be fully examined.
Amongst the candidates to regulate optimal T cell amoeboid motility in lymphoid tissues, nonmuscle myosin IIA (A003748; also called NMM-IIA) is speculated to have an important role. Myosin IIA is the only class II myosin expressed in mouse T lymphocytes and is regulated during T cell arrest mediated by engagement of the T cell antigen receptor 13 . In three-dimensional collagen matrices, dendritic cells (DCs) fail to squeeze through packed collagen fibers when myosin II motor function is blocked 7 . Myosin IIA has also been shown to have an important role in mediating efficient T cell migration in vitro in two-dimensional environments 13, 14 . In some model systems, myosin IIA activity is also important in mediating uropodal detachment from highly adhesive surfaces such as substrates coated with the intercellular adhesion molecule ICAM-1 (A002871) 15, 16 .
T cells can move by two distinct modes of motility in two-dimensional environments depending on the adhesiveness of the substrate and on myosin IIA activity 14 . On low-adhesive two-dimensional surfaces, T cells show fast amoeboid crawling motility that requires myosin IIA-generated contractile forces and uses multiple concurrent surface contacts ('walking'). In contrast, on highly adhesive surfaces, T cell crawling uses a single-surface contact, resembles the migration of fibroblasts and epithelial cells and is driven mainly by actin polymerization ('sliding'). Data also indicate that myosin IIA activity restricts surface adhesion on two-dimensional substrates 14 , but the relevance of this finding to motility in lymph nodes and highly confined environments with many possible surface contacts is unclear. The interaction of confinement, provided in three-dimensional environments, and adhesiveness during motility also remains unexplored.
Here we show that myosin IIA function had a role in many steps of T cell trafficking, including interstitial migration of T cells and lymph node retention. Ablation of myosin IIA led to many defects, which 9 5 4 VOLUME 11 NUMBER 10 OCTOBER 2010 nature immunology A r t i c l e s broadly suggested a generalized lack of cortical control and promiscuous cell-substrate interactions. Using engineered 'microchannels' designed to provide various amounts of confinement, such as those that may be found in tissues in vivo, we found that myosin IIA was a key participant in facilitating rapid motility and the ability to release from one surface contact and move to another. As in two-dimensional environments, myosin IIA allowed cells under confinement to maximize their speed. Notably, the main determinant of the optimal environmental and intracellular conditions required to achieve rapid motility was an ideal degree of confinement coupled with myosin IIA function, and this optimum was less dependent on integrin density than it was in two-dimensional mesenchymal models. Using total internal reflection fluorescence (TIRF) imaging, we found that under these optimum conditions, T cells migrated by a walking mode. This myosin IIA-dependent motility mode permitted T cells to make selective contacts with the substrate, minimizing their effective drag and allowing rapid movements between surfaces and in complex and dense environments.
RESULTS
T cells from mice with conditional knockout of myosin IIA T lymphocytes alternate between walking and sliding modes of motility based in part on myosin IIA activity 14 , and we sought to determine how these mechanisms function in interstitial environments. Myosin IIA is the only class II myosin expressed in mouse T cells 13 , and germline knockout of the gene encoding myosin IIA results in embryonic death 17 . To eliminate myosin IIA specifically from naive T cells, we used a Cre recombinase-mediated conditional knockout strategy targeting the gene encoding the myosin IIA heavy chain (Myh9; Supplementary Fig. 1 ). We deleted myosin IIA expression during the single-positive stage of thymocyte development by crossing mice with loxP-flanked Myh9 alleles (Myh9 flox/flox ) with a transgenic mouse line expressing Cre recombinase under the control of a modified distal promoter of the gene encoding the kinase Lck (Lck-Cre) 18 . As controls for our experiments, we used either Myh9 wt/wt -Lck-Cre + mice or Myh9 flox/flox -Lck-Cre − mice and obtained similar results with each. The Myh9 flox/flox -Lck-Cre + (MyoIIA-cKO) mice had normal percentages of single-positive CD4 + and CD8 + thymocytes (Fig. 1a) . Mature T cells were present in the periphery, although MyoIIA-cKO mice had fewer CD8 + T cells than did control (Myh9 wt/wt -Lck-Cre + ) mice (Fig. 1a) . On average, the frequency of CD8 + T cells in lymph nodes was 22.1% for control mice and 13.9% for MyoIIA-cKO mice, and 13.9% and 7.0%, respectively, in the blood. The lower numbers were probably due to shorter long-term survival of the myosin IIA-deficient CD8 + T cells in the periphery rather than a thymic exit defect, given the normal thymic populations. Furthermore, when we compared the ratio of the percentage of CD8 + T cells in the lymph nodes of MyoIIA-cKO mice to that of CD8 + T cells in the lymph nodes of control mice (63% of control) with the ratio of the percentages in the blood (50% of control), this suggested a trend toward accumulation of CD8 + T cells in the lymph nodes of MyoIIA-cKO mice.
The total pool of naive CD8 + MyoIIA-cKO T cells expressed one third the myosin IIA protein detected in control cells (Fig. 1b) . This was apparently the result of partial Cre expression in this population, as on average, ~85% of MyoIIA-cKO CD8 + T cells had much lower expression of myosin IIA protein, but a subpopulation of ~15% of CD8 + T cells had myosin IIA expression similar to that of control cells (Fig. 1c) . To confirm the efficacy of our conditional knockout approach and the penetrance of Cre expression in T cell populations, we crossed control and MyoIIA-cKO mice with transgenic mice containing a knock-in of yellow fluorescence protein (YFP) in the Gt(Rosa)26Sor locus 19 (Rosa-YFP mice). In these mice, YFP expression is dependent on Cre expression as a result of an upstream stop codon cassette flanked by loxP sites. We determined that in control (Myh9 wt/wt -Lck-Cre + ) and MyoIIA-cKO Rosa-YFP mice, Cre expression was present in 80-95% of CD8 + T cells but in only 50-60% of CD4 + T cells (Fig. 1d) . Immunoblot analysis of sorted Rosa-YFP + CD8 + T cells from control and MyoIIA-cKO mice routinely demonstrated that Cre + CD8 + T cells from MyoIIA-cKO mice had ~90% lower myosin IIA protein expression (Fig. 1e) . This confirmed efficient deletion of myosin IIA in Cre-expressing Myh9 flox/flox cells. It is possible that after myosin IIA deletion, other class II isoforms could be upregulated in T cells. However, we did not detect expression of (Fig. 1f) . On the basis of our results for Cre penetrance in CD4 + versus CD8 + T cell subsets, we focused our work on the motility of CD8 + T cells. To avoid subjecting naive T cells to cell sorting, and given that on average 85% of CD8 + T cells from MyoIIA-cKO mice had efficient depletion of myosin IIA, we used total CD8 + T cells for our subsequent experiments.
Myosin IIA regulates adhesion under flow Analysis of differently labeled transferred myosin IIA-deficient and control T cells did not show a gross alteration of their overall localization in lymph node T cell zones 2 h after transfer. However, loss of myosin IIA resulted in a ~60% greater frequency of contact of MyoIIAcKO naive T cells with high-endothelial venules (HEVs) at this time point (Fig. 2a,b) . Rolling and firm adhesion are critical steps in T cell extravasation, and a possible reason for the observed accumulation of MyoIIA-cKO cells at HEVs could have been more adhesion, particularly under flow. Therefore, we measured the ability of myosin IIA-deficient T cells to adhere and remain attached to ICAM-1-coated surfaces in the presence of chemokine under physiological shear flow. Naive MyoIIA-cKO T cells had twofold greater adhesion to ICAM-1 under flow (Fig. 2c) , which confirmed our finding of overadhesion in vivo. However, when we next measured the ability of myosin IIA-deficient naive T cells to transmigrate through endothelial cell monolayers plated on Transwell membranes, MyoIIA-cKO naive T cells had ~50% less migration across endothelial cells than did control naive T cells (Fig. 2d) . To rule out the possibility that the greater adhesion of myosin IIA-deficient T cells in vitro and in vivo was due to altered surface expression of chemokine or adhesion receptors, we verified that naive control and myosin IIA-deficient CD8 + T cells had similar expression of the chemokine receptor CCR7, the lymph node-homing receptor L-selectin (A001417; CD62L) and the integrin α L β 2 (LFA-1; Fig. 2e ).
Myosin IIA controls interstitial T cell motility in vivo
To address how modulation of actomyosin dynamics by myosin IIA affected T cell interstitial migration in the lymph nodes, we used two-photon microscopy analysis of adoptively transferred naive control and MyoIIA-cKO CD8 + T cells. MyoIIA-cKO T cells had much shorter track lengths and less displacement from their origin (Fig. 3a,b and Supplementary Movie 1). Myosin IIA-deficient cells showed a 26% average lower median speed and a lower frequency of cells that reached peak instantaneous velocities (Fig. 3c) . The median turning angle between time points of MyoIIA-cKO T cells was also increased from 47.5° to 54° per turn (Fig. 3d) . Although these defects were numerically modest, they compounded over time and resulted in an average decrease of 45% in the mean square displacement of myosin IIA-deficient T cells over a 10-minute time period (Fig. 3e) . Furthermore, the average motility coefficient, used as a measure of the volume a cell can survey over time 20 , was decreased by 49% (P = 0.009) over a 10-minute time period in MyoIIA-cKO T cells, from 27.7 μm/√min to 14.2 μm/√min. MyoIIA-cKO T cells also had a greater frequency of arrested cells (26.8% versus 11.6%; P = 0.0118), defined as cells that do not move more than 10 μm from their origin during an interval of 5 min or more.
The greater confinement of MyoIIA-cKO T cells could be attributed to an inability to sense and follow a directional chemotactic cue. To assess this, we measured both chemotactic migration (response to a directional gradient of chemokine) and chemokinetic migration (response to the presence of chemokine) of naive control and myosin IIA-deficient CD8 + T cells across 5-μm pore Transwells. MyoIIA-cKO T cells showed 64% less chemotaxis toward the chemokine CCL21 than did control cells (Fig. 3f) . However, chemokinesis was inhibited to the same extent, which suggested that the migration defects were not due exclusively to impaired chemotaxis of myosin IIA-deficient T cells. 
A r t i c l e s
Myosin IIA regulates the lymph node recirculation of naive T cells The transmigration and interstitial motility defects of myosin IIAdeficient T cells prompted us to characterize the role of this myosin in the trafficking and recirculation of naive T cells. After adoptive transfer, we observed more myosin IIA-deficient naive CD8 + T cells than control naive CD8 + T cells in lymph nodes (Fig. 4a) . This accumulation increased over time between 2 h and 42 h after transfer, to a maximum of 1.9-fold (Fig. 4b) . This could potentially have been caused by more entry into and/or less egress from lymph nodes. Our data on in vitro transendothelial migration of MyoIIA-cKO T cells indicated that greater entry was unlikely. To determine whether impaired exit from lymph nodes had a role in this accumulation, we adoptively transferred control and MyoIIA-cKO T cells into recipient mice and allowed them to equilibrate for 24 h, then blocked further T cell entry into lymph nodes through the use of blocking antibody to CD62L (anti-CD62L). There were 3.3-fold more naive myosin IIA-deficient T cells than naive control T cells in mice treated with anti-CD62L, compared with 1.8-fold in the absence of entry blockade (Fig. 4c) . This indicated that myosin IIA has a role in the rate at which T cells exit lymph nodes. Given the greater adhesion of MyoIIA-cKO T cells to ICAM-1 and on HEVs, we also used LFA-1-and integrin α 4 -blocking antibodies to rule out the possibility that MyoIIA-cKO T cells could be entering lymph nodes even after CD62L blockade. The 3.2-fold greater number of myosin IIA-deficient T cells relative to that of control cells under this blockade confirmed that the accumulation of MyoIIA-cKO cells was due largely to lymph node retention (Fig. 4d) .
Myosin IIA-deficient T cells did not show significantly more accumulation at the surface of lymphatic sinuses (Fig. 4e,f) , which suggested that less exit from lymph nodes was probably due to more interstitial confinement of myosin IIA-deficient T cells rather than to deficiencies in passage through the sinuses.
Optimal confinement and myosin IIA maximize motility Given the three-dimensional organization of the lymph node and that directional chemotaxis of MyoIIA-cKO T cells was not completely abrogated, we hypothesized that the myosin IIA-dependent migration defects could be caused by overadherence to surrounding surfaces in confined environments. Therefore, we sought a method to delineate the role of cellular adhesion and contractility during migration in three-dimensional environments as a contributor to the in vivo migration defects of MyoIIA-cKO T cells. For this we used microfabricated channels (microchannels) 21 of various sizes to provide a platform in which T cells could be variably confined in two dimensions while allowing motility in the third dimension (Fig. 5a) . We created these channels with a constant ceiling height and with variable width to either confine the cells or allow them to meander to different degrees from side wall to side wall ( Fig. 5b and Supplementary Movie 2) . Microchannels can be assembled on glass coverslips, allowing imaging of the details of the adhesive contacts (by TIRF microscopy) on one surface during migration and extrapolation of the nature of these contacts to the other dimensions. We used activated T cells for most of these experiments, as they had myosin IIA-dependent defects similar to those of naive T cells when analyzed both in vivo ( Supplementary  Fig. 2 ) and during transmigration in vitro (data not shown).
First we analyzed whether the degree of confinement affected T cell motility. For these experiments we used microchannels with -80
Ctrl MyoIIA-cKO a fixed ceiling height of 7 μm, a dimension similar to the girth of an activated T cell. We also determined how differences in the adhesiveness of the substrate may influence confined T cell migration by coating the microchannels with fibronectin, ICAM-1 or casein (which is not an integrin ligand and blocks the binding of integrin ligands to the substrate; Fig. 5c-e) . In all cases, we observed peak velocity at optimal confinement and lower speed for cells too tightly or too loosely enclosed. In microchannels with widths that approximated their girth (7-9 μm), T cells migrated at a peak average velocity that exceeded 20 μm/min in the presence of the integrin substrates fibronectin and ICAM-1 (Fig. 5c,d ). T cell speed was lower at smaller microchannel widths (4-5 μm), probably because of more cell surface friction along the channel walls. The other extreme of less confinement (12-to 20-μm microchannels) was also nonoptimal, as we observed lower speed, possibly due to suboptimal availability of surfaces to push off and adhere to or to inefficiencies associated with protrusions in directions orthogonal to the direction of propagation. Notably, although T cells migrating in casein-coated microchannels did not achieve the same average speeds detected in fibronectin-and ICAM-1-coated microchannels, we still observed a similar confinement-dependent distribution of migration velocities in control cells (Fig. 5e) . This suggested that confinement is a chief determinant of motility speed and only to a lesser extent is the presence of integrin substrate necessary to achieve this optimum.
To characterize the role of myosin IIA in migration in microchannels, we used the class II myosin chemical inhibitor blebbistatin 22 and imaging conditions that avoid photoinactivation and toxicity of this drug. The use of blebbistatin gave us the ability to acutely and completely inhibit the function of myosin IIA, complementing the MyoIIA-cKO approach. Under these conditions, inhibition of myosin IIA resulted in an overall lower motility of activated T cells across all microchannel sizes, with average speeds that did not change much relative to the confinement (Fig. 5c-e) . In particular, under conditions in which control cells achieved maximal motility (7-to 8-μm microchannels), T cells with inhibited myosin IIA did not have an average speed much greater than their speed in microchannels with more or less confinement. This suggested that myosin IIA function is required not only for fast motility in general but specifically for T cells to adapt their motility mode to the environment. Furthermore, as we observed similar motility rates when myosin IIA was blocked in the casein-and integrin-substrate coated conditions, we conclude that the function of myosin IIA in optimizing motility is not strictly dependent on the binding of integrin to the substrate.
Further analysis of T cell motility in larger microchannels (greater than a cell width) coated with fibronectin provided additional evidence to support the idea of complex interaction of surface contacts. In this setting, activated T cells constantly switched adherence (weaved) between opposing walls of the microchannel rather than crawling forward along one of the channel walls ( Fig. 6a and  Supplementary Movie 3) . Such weaving could result from a T cell analog of the 70° average bifurcation in the protrusions generated during motility in Dictyostelium 23 . T cells with inhibited myosin IIA became more adherent to the channel walls between weaves, which resulted in a much lower weaving frequency (Fig. 6a and  Supplementary Movie 4) . Blebbistatin-treated T cells had a doubling of the time that elapsed from initial adhesion to one side wall of the channel to contact with the other (weaving cycle; Fig. 6b) . This was not a function of the lower velocity of myosin IIA cells in the presence of blebbistatin, as shown by the finding that the adhesion time to a channel wall of T cells with inhibited myosin IIA was also doubled (Fig. 6b) . In sum, these experiments indicate that myosin IIA functions to limit adhesion to the substrate for confinementoptimized motility.
To specifically analyze the nature of the coupling of cells to surfaces under three-dimensional confinement, we used TIRF microscopy of T cells in microchannels to visualize the adhesive contacts 
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A r t i c l e s on the surface nearest the objective. Loss of myosin IIA results in a shift in the crawling mode of CD4 + T cell clones during twodimensional migration, which is associated with more adherence 14 . TIRF imaging of activated control T cells in microchannels indicated that these cells migrated mainly by amoeboid crawling with multiple small independent surface contact points (walking; Fig. 6c,d and Supplementary Movie 5). Thus, although cells seemed elongated, they were effectively 'choosing' only specific points of the membrane for surface contact, thereby potentially limiting frictional drag while permitting dynamic scanning of new areas. Blebbistatin-induced loss of myosin IIA activity resulted in a change in motility mode, with T cells mainly crawling using one large adhesion area (sliding) and with prolonged contacts on a given microchannel wall (Fig. 6c,d and Supplementary Movie 6). Although cells using this mode are still able to crawl forward, this mode results in more drag surface that involves a greater portion of the cell cortex and probably slows the cell. Finally, although it was technically challenging because of their lower motility and entry into microchannels, we also analyzed the migration of naive T cells in microchannels (with a ceiling height of 3 μm because of their smaller size). Generally, naive T cells were less motile than activated T cells, particularly under less confinement (channels >10 μm; Supplementary Fig. 3) ; this also confirmed that larger channels do not support optimal motility rates. Nonetheless, comparison of the migration of control and MyoIIA-cKO naive T cells in microchannels with a width of 4 μm or 8 μm supported the idea of a role for myosin IIA as a determinant in optimizing T cell motility in confinement (Supplementary Fig. 3 ).
Overadhesion of myosin IIA-deficient T cells TIRF microscopy showed that blebbistatin-treated activated CD8 + T cells had a significantly greater adhesion area than did vehicletreated activated CD8 + T cells when plated on casein-or ICAM-1-coated surfaces (Fig. 7a,b) . This was also true for MyoIIA-cKO naive CD8 + T cells compared with control naive CD8 + T cells plated on ICAM-1 (Fig. 7c) . The adhesion area of naive T cells plated on casein coated surfaces was too small to be consistently detected by our TIRF imaging method. Furthermore, similar to published observations 13 , inhibition of myosin IIA also resulted in an altered cell morphology, with more rounding of activated T cells, as shown by measurement of their shape factor (which indicates how circular a cell is) and ellipticity (cell length/cell breadth; Supplementary Fig. 4) . Overall, these data are consistent with the idea of a role for myosin IIA in modulating T cell surface contacts in both the presence and absence of integrin ligands.
In vivo in the lymph node paracortex, T cells are believed to follow tracks defined by a dense network of fibroblastic reticular cells (FRCs) 24 , and it has been shown that FRCs can provide chemokines to support the adhesion and migration of T cells 25, 26 . Therefore, we tested whether overadhesion of T cells in the absence of myosin IIA function resulted in more contact with FRCs and caused the slower and more meandering motility of MyoIIA-cKO T cells in vivo. To determine the extent of adhesion of T cells to FRCs in vivo, we generated bone marrow chimeras by reconstituting irradiated mice expressing cyan fluorescent protein (CFP) under control of the actin promoter (actin-CFP mice) with bone marrow cells from wild-type mice 24 . Imaging of labeled control and MyoIIA-cKO naive T cells transferred into the chimeric mice did not show a significant difference in the percentage of MyoIIAcKO naive T cells or control cells that potentially interacted with FRCs in lymph nodes (Fig. 7d) .
We therefore considered other cells present in lymph nodes as candidates for adhesion and frictional drag. We quantified the adhesion of T cells to other lymph node-dwelling cells, such as lymphatic endothelial cells, DCs and other T cells. Our in vitro coupling data confirmed that myosin IIA-deficient naive T cells did not interact more with FRCs and showed that their percentage of attachment to (Fig. 7e) . However, MyoIIA-cKO T cells had ~60% more attachment to other T cells than did control cells (Fig. 7e) . In the T cell zones of lymph nodes, T cells are probably constantly in proximity with other surrounding lymphocytes, and these prolonged interactions would be predicted to cause excessive drag, resulting in less motility and more meandering in vivo.
DISCUSSION
Lymphocyte migration in vivo relies on coordinated regulation of actin polymerization and branching, as suggested by work with T cells deficient in upstream regulators of the actin-nucleator protein Arp2/3, such as WASP 27 , Dock2 (ref. 28 ) and coronin-1A 29, 30 . However, the role of class II myosin during interstitial T cell migration has remained unknown. Our work here has indicated a requirement for myosin IIA function in lymphocyte migration and trafficking in vivo. Notably, we have provided new insight into the extent and dynamics of surface contacts as important factors regulating three-dimensional lymphocyte migration. Microfabricated channels allowed us to recapitulate some aspects of the environmental confinement that lymphocytes may encounter in vivo and permitted us to demonstrate the existence of a confinement optimum for amoeboid motility. The presence of integrin ligands had only a limited effect on this optimization, in contrast to what would be 
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A r t i c l e s predicted from the haptokinetic model and in agreement with studies of leukocyte migration in vivo 7, 8 . Indeed, faced with low-adhesive substrates, amoeboid cells can adapt by increasing actin-polymerization rates during protrusion to compensate for less force-coupling 31 . This is also consistent with the idea of 'chimneying' described for cells crawling between adjacent coverslips 32 .
Under ideal confinement, we observed migration speeds of over 20 μm/min; these were greater than average speeds but equivalent to the highest instantaneous speeds reported for motility in lymph nodes. This could have been due to the fact that individual microchannels provide a consistent and in some cases optimized environment (~8-μm channels) for T cell migration. In contrast, in lymph nodes, lymphocytes probably encounter various microenvironments with different characteristics, which may modulate motility speeds and limit peak velocities. Furthermore, in the absence of myosin IIA function, T cells did not achieve optimal motility in microchannels, probably because of hyperadhesion and spreading, which cause more friction and drag. In this context, regulation of cortical tension and adhesion by myosin IIA can modulate the ability of lymphocytes to adapt their morphology to optimize their interaction with the environment during motility.
We propose that the motility optimum is reached at amounts of confinement at which three things coincide. First, the ability to contact and exert force on multiple adjacent surfaces is maximized, which optimizes frictional coupling without the need for highly specific protein-protein interactions. Second, inefficiencies from actin-based protrusion along incorrect axes are minimized. Third, the cell can restrict the extent of cortical contact with the substrate, minimizing excessive drag. Under extreme confinement, the size and rigidity of the nucleus may limit how thin the cell can become, forcing the cortex to drag along even when not in use for force coupling. It has been proposed that myosin IIA might overcome such nucleus-induced drag when dendritic cells migrate through dense collagen matrices 7 . That report, however, speculated that myosin IIA functioned as a squeezing force, which may be a separate function for this motor.
Morphologically, the walking mode facilitated by myosin IIA used multiple contacts that may be somewhat similar to the eupodia described for the amoeba Dictyostelium 33 . Molecular imaging has shown that clusters of myosin IIA move inward toward the center of these contacts and that this movement is coincident with extinguishing of the contact and release from the substrate 14 . Our data are in agreement with work showing that two-dimensional motility in Dictyostelium relies on myosin II contractility to provide cortical tension and de-adhesion from the substrate 34 . Further evidence for the involvement of myosin IIA in the disassembly of actin and thus a potential function of myosin IIA in extinguishing cortical adhesive contacts with the substrate has been reported 35 . A millipede motility mode during migration along the inner face of HEVs 36 may also be a variant of this walking mode.
A general theme emerging from our work is a role for myosin IIA in controlling adhesion independently of substrate composition. Thus, T cells lacking myosin IIA overadhere to HEVs, other T cells and artificial substrates, whether they are coated with integrin ligands or blocked from integrin binding. This is partly consistent with reports suggesting that myosin IIA has a role in uropodal detachment from highly adhesive integrin ligand-coated two-dimensional surfaces 15, 16 . This has been proposed to involve linkage of myosin IIA to LFA-1 to mediate de-attachment without affecting the regulation of LFA-1 affinity 15 . Although our results do not exclude such a possibility, we prefer the interpretation that the role of myosin IIA in adhesion may be indirect and not strictly linked to integrin adhesion. The specific effects that were confined to the uropod in the previously published studies could have been due to the specific adhesive properties of the surfaces, cells or drugs used in those different experimental systems.
In sum, our data suggest that the greater turning and lower velocity of MyoIIA-cKO T cells in vivo may be determined by a diminished capacity to limit contacts with their environment. We did not find evidence that the FRC network was a substrate for this greater adhesion in vivo. However, our results indicate that the overadhesive properties of myosin IIA-deficient T cells caused abnormal attachment to other T lymphocytes. In the lymph node, even brief spreading of the cell cortex of one T cell onto the cortex of another, particularly when cells are moving with opposite trajectories, would oppose efficient forward movement. Although it has been reported that loss of myosin IIA can affect neutrophil polarity 37 and alter T cell morphology 13 , our data suggest that loss of polarity is not the main defect of T cells depleted of myosin IIA. In particular, in microchannels we did not observe excessive directional changes of cells in which myosin IIA was inhibited, and their lower response to a chemotactic gradient was probably secondary to their overadhesion.
Overall, our findings suggest that by limiting surface adhesion and providing contractile force, myosin IIA optimizes lymphocyte crawling efficiency in the many environments T cells must pass through during their trafficking. In contrast to a switch in motility rate mediated only by integrins, as predicted with haptokinetic models, we propose a switch in motility rate affected by the density (degree of confinement) of the tissue and by modulation of myosin IIA function. Such a motility switch for T cells might also occur during early activation, which leads to phosphorylation of the myosin heavy chain in response to calcium signaling 13 . This can result in the reorganization of myosin filaments 38 , leading to regulation of the ability of myosin IIA to crosslink and contract the actin network. Modulation of myosin IIA activity can therefore be considered an important regulator of T cell trafficking and potentially surveillance through the modulation of cell stopping.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Accession codes. UCSD-Nature Signaling Gateway (http://www. signaling-gateway.org): A003748, A002871 and A001417. Transwell migration assay. Purified naive CD8 + T cells from control and MyoIIA-cKO mice were labeled with 1 μM CFSE or 10 μM CMTMR, were mixed at a ratio of 1:1 and were used for Transwell migration assays. Labeled T cells (1 × 10 6 ) resuspended in RPMI medium supplemented with 1% (wt/vol) fatty acid-free BSA (Calbiochem) and 10 mM HEPES, (stock pH, 7.2-7.5) were added to the top chamber of each Transwell plate (Corning), and cells were allowed to migrate for 1 h at 37 °C in the presence or absence of chemokine. Migrated T cells were then collected from the bottom well and were quantified for a fixed period of time (2-3 min) on a FACSCalibur (BD Biosciences). A known amount of cells, acquired for the same amount of time, was used as a standard for determining the number of migrated cells.
Lymph node staining. At 2 and 48 h after adoptive transfer of control and MyoIIA-cKO naive T cells labeled with 1 μM CFSE or 10 μM CMTMR, popliteal lymph nodes of recipient mice were collected and snap-frozen in optimum cutting temperature compound (Tissue-Tek). Lymph node sections 10 μm in thickness were fixed with 1% (vol/vol) paraformaldehyde, then were blocked and stained. Anti-PNAd-1 was used for visualization of HEVs, and anti-LYVE-1 was used to highlight lymphatic sinuses. Images of whole lymph node sections were acquired on a confocal microscope with the scan-slide function of Metamorph (Universal Imaging). Data were then analyzed with Imaris software for the identification of T cells on the basis of their CFSE or CMTMR fluorescence, followed by the creation of a surface mask of the stained HEVs or lymphatic sinuses. The frequency of T cells in contact with HEV surfaces or lymphatic sinuses was then quantified with the 'spot-to-surface distance' function of Imaris. Multiple lymph node sections were analyzed with an average of 50 cells per group per lymph node section. An average of four lymph node sections per experiment was analyzed.
T cell lymph node homing and egress. Control and MyoIIA-cKO T cells were labeled with 1 μM CFSE or 10 μM CMTMR and mixed at a ratio of 1:1, and 2 × 10 6 to 4 × 10 6 T cells were injected intravenously into recipient mice. At 2, 18 or 42 h after adoptive transfer, lymph nodes, blood and spleens were collected from the recipient mice. After dissociation of lymph nodes and spleens, the frequency of transferred control and MyoIIA-cKO T cells was quantified by flow cytometry and the ratio of MyoIIA-cKO to control T cells in the blood, inguinal lymph nodes and spleen of recipient mice was determined. The ratios in lymph node and spleen were normalized to the ratio in blood to correct for potential differences in the input or survival of control and MyoIIA-cKO cells.
For analysis of the egress rate and lymph node retention of control and MyoIIA-cKO T cells, transferred T cells were allowed to equilibrate for 24 h in recipient mice and then the mice were treated with PBS or entry-blocking antibodies. Anti-CD62L or a combination of anti-LFA-1 and anti-integrin α 4 was used with similar results. At 18 h after the treatment with blocking antibody, the ratio of MyoIIA-cKO T cells to control T cells retained in the inguinal lymph nodes of recipient mice was assessed as described above.
Adhesion to ICAM-1 under flow. Naive control and MyoIIA-cKO CD8 + T cells were labeled with 1 μM CFSE or 10 μM CMTMR, mixed at a ratio of 1:1 and injected into flow chambers (IBIDI) for 2 min at a shear flow of 0.25 dyne/ cm 2 , then were subjected to 10 min of physiological shear flow (2 dyne/cm 2 ). Brightfield and fluorescent images were then acquired and adherent cells at the end time point were quantified with Metamorph software.
Microchannel fabrication and imaging. Microchannel fluidic devices were fabricated by a soft lithography technique with PDMS (polydimethylsiloxane; Sylgard Elastomer 184 kit; Dow Corning) as described 21 . PDMS was poured onto the stamp and left to cure overnight under vacuum; once solidified, the PDMS with embedded microchannels was then cut from the mold and an entry port was cut adjacent to the channel structures. The PDMS and a glassbottomed imaging dish (Fluoro Dish, World Precision) were then activated for 30 s in a plasma cleaner (Harrick Plasma) and bonded to each other. After 1 h of incubation at 55 °C, microchannel imaging chambers were then put back in the plasma cleaner and left under vacuum for 5 min, after which the plasma source was activated for 15 s. Immediately after that step, 10 μl fibronectin solution (50 μg/ml), ICAM-1 solution (5 μg/ml) or casein solution (20 μg/ml) was injected into the entry area of the microchannels to coat them. After 1 h of incubation at 37 °C, excess coating proteins were washed out with PBS and imaging media was added. T cells (1 × 10 5 to 3 × 10 5 cells resuspended in 10 μl) were then added to the entry port and were allowed to spontaneously enter the channels at 37 °C for 2-4 h (for activated T cells) or overnight (for naive T cells). T cells crawling in the microchannels were then imaged for 1-6 h at intervals of 30 s or 90 s with a 20× phase-contrast objective or a 20x brightfield objective. T cells remained alive and motile for the entire period of recording. Metamorph software (Molecular Devices) was used for calculation of cell speed, adhesion time and weave cycle. Typically a minimum of ten cells per microchannel width per treatment condition were analyzed. TIRF microscopy. A modified Axiovert 200M microscope fitted with a Zeiss TIRF slider and a 100× oil-immersion objective with a numerical aperture of 1.45 was used for TIRF imaging. TIRF images were acquired with a liquid-cooled intensified charge-coupled device camera (model XR/Mega-10Z; Stanford Photonics). The TIRF microscope was equipped with 491-nm (50-mW) and 561-nm (25-mW) solid-state lasers (Cobolt) and excitation wavelength was selected through an acousto-optic tunable filter (Neos). Emission wavelengths were selected through the combination of a multipleedged dichroic and multiple-pass emission filter. The control and imaging software was InVivo (QED Imaging; Media Cybernetics). The microscope was configured with a heated stage to maintain a sample temperature of 37 °C.
For TIRF imaging of surface adhesion zones, activated T cells were labeled with 4 μM CMTMR. T cells (5 × 10 4 ) were plated overnight in glass chamber slides or alternatively T cells (1 × 10 6 ) were injected into microchannels of various sizes. For time-lapse experiments, brightfield and TIRF fluorescence images were acquired every 5 s for 5 min. For the prevention of photoinactivation, crosslinking and toxicity of blebbistatin, which may occur after illumination with light of a wavelength less than 500 nm (ref. 40) , TIRF imaging of blebbistatin-treated cells was done with CMTMR labeling and illumination of the cells with a 561-nm laser.
Contact areas were measured with Metamorph software, a threshold was set for the CMTMR fluorescence in the TIRF channel and the area of the fluorescent region was then calculated with the region statistics function of Metamorph. The crawling mode was assessed as described 14 : if the CMTMR TIRF fluorescence during the time lapse showed only one main adhesion area, the cell was considered to be sliding; if multiple distinct adhesion zones were present, the cell was considered to be walking. The crawling mode of cell with multiple adhesion zones was considered to be mixed if it consecutively presented a single adhesion zone for more than half the duration of a time lapse. The shape factor, which indicates how closely a cell resembles a circle, was calculated as follows: (4 × π × area) / perimeter 2 , with values close to 0 indicating an elongated cell and a value of 1 representing a perfect circle. T cell ellipticity was calculated as follows: cell length (span of the longest cord through the cell) / cell breadth (width of the cell perpendicular to the longest cord). These morphology parameters were calculated with Metamorph with the brightfield images acquired during TIRF imaging.
Stromal cell lines.
Primary cell lines of lymphoid stroma were obtained by complete digestion of C57BL/6J lymph nodes with collagenase A and collagenase D according to a published protocol 26 . After complete digestion, the final cell pellet was sorted for FRCs (CD45 − CD35 − CD31 − gp38 + ) or lymphatic endothelial cells (CD45 − CD35 − CD31 + gp38 + ).
T cell coupling assay. Naive control and MyoIIA-cKO CD8 + T cells were labeled with 1 μM CFSE and coupled to FRCs, lymphatic endothelial cells, DCs or wild-type T cells labeled with 10 μM CMTMR. For coupling, cells were spun together for 1 min at 200g and were incubated for 10 min at 37 °C, then were gently resuspended and then fixed with 1% (vol/vol) paraformaldehyde. Cells were then washed and the frequency of conjugate formation was quantified by flow cytometry.
Statistical analysis. Prism software (GraphPad) was used for graphing the data and for calculation of statistical significance by Student's t-test for single comparisons or analysis of variance for multiple comparisons, followed by post-hoc Tukey tests on continuous variable data, which was normally distributed and had equal variance. Alternatively, Kruskal-Wallis or Mann-Whitney tests were used for non-normally distributed data for determination of statistical significance, followed by Dunn post-tests for calculation of P values for multiple comparisons. The chi-squared test was used for calculation of the significance of nominal variable data.
